Approved · Notification · Phase 1 · decided in 35 days, 9 Sept 2026
Danaher Corporation proposes to acquire StatLab Medical Products via a Stock Purchase Agreement. This transaction unites two key players in the anatomical pathology sector, with both Danaher (through Leica Biosystems) and StatLab supplying core histology instruments and consumables. The acquisition is structured as a share sale.
Danaher Corporation (Danaher) proposes to acquire StatLab Medical Products (StatLab) through a Stock Purchase Agreement with SLMP Intermediate Holdings, Inc and StatLab (the Acquisition). Danaher is a global science and technology company that designs, manufactures and markets professional, medical, industrial and commercial products and services under three core segments: biotechnology, life sciences and diagnostics. Danaher, through its subsidiary Leica Biosystems, supplies anatomical pathology equipment, consumables and workflow solutions, including core histology instruments and consumables. StatLab develops, manufactures, distributes and services pre-analytical and staining consumables and instruments that support the anatomical pathology workflow. StatLab primarily supplies core histology consumables, but also supplies core histology instruments.